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A substantial number of studies on basal forebrain (BF) cholinergic neurons
(BFCN) have provided compelling evidence for their role in the etiology of stress,
cognitive aging, Alzheimer’s disease (AD), and other neurodegenerative diseases.
BFCN project to a broad range of cortical sites and limbic structures, including
the hippocampus, and are involved in stress and cognition. In particular, the
hippocampus, the primary target tissue of the glucocorticoid stress hormones,
is associated with cognitive function in tandem with hypothalamic-pituitary-adrenal
(HPA) axis modulation. The present review summarizes glucocorticoid and HPA axis
research to date in an effort to establish the manner in which stress affects the
release of acetylcholine (ACh), glucocorticoids, and their receptor in the context of
cognitive processes. We attempt to provide the molecular interactive link between
the glucocorticoids and cholinergic system that contributes to BFCN degeneration in
stress-induced acceleration of cognitive decline in aging and AD. We also discuss
the importance of animal models in facilitating such studies for pharmacological use,
to which could help decipher disease states and propose leads for pharmacological
intervention.
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Introduction
Since its inception, the cholinergic hypothesis has generated considerable interest. It has
been used to decipher the different orchestrating functions and dysfunctions in the nervous
system associated with Alzheimer’s disease (AD) and other neurodegenerative diseases. This
hypothesis has been used to further understand cognitive impairment and neurodegenerative
diseases by evaluating and tracing brain functions in normal and aging brains (Gallagher
and Colombo, 1995; Contestabile, 2011). The main components of the cholinergic pathway
are: (1) the neurotransmitter acetylcholine (ACh); (2) acetylcholinesterase (AChE), which
breaks down ACh; (3) choline acetyltransferase, an enzyme that synthesizes ACh; and
(4) ACh receptors, specifically the nicotinic ACh receptor, and the muscarinic ACh receptor
(mAChR). Evidence from previous research on normal aging (Drachman et al., 1982),
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AD (Whitehouse et al., 1982), and anti-cholinergic (Newhouse
et al., 1988, 1994) and pro-cholinergic drug administration
(Davis and Mohs, 1982) supports the major role of the
cholinergic system in aged-related cognitive decline. Extensive
research has established the relationship between cognitive
impairment and the cholinergic system in the basal forebrain
(BF; Baxter and Chiba, 1999). The involvement of the cholinergic
system in regulating stress is also evident from studies
that acute/inescapable stress enhanced release of ACh and
induced expression of genes that regulate ACh availability in
the hippocampus and prefrontal cortex (Mark et al., 1996;
Kaufer et al., 1998). Cognitive processes are influenced by the
acute and chronic stress-induced release of glucocorticoids,
stress hormones that influence the function of the prefrontal
cortex and hippocampus (Popoli et al., 2011). Stress and
stress hormone plays a well-established role in mental health
and impaired cognition. It is correlated with hippocampal
volume and age-related cognitive decline (Lupien et al., 1994,
2009), suggesting that sustained stress, via glucocorticoid
hypersecretion, leads to hippocampal damage (Uno et al., 1989).
Prolonged overproduction of glucocorticoids can be detrimental
to brain structure, whereas insufficient glucocorticoid signaling
can lead to stress-related pathological conditions (Raison and
Miller, 2003). This emphasizes the need for the careful regulation
of glucocorticoid exposure. Impairment of the hypothalamic-
pituitary-adrenal (HPA) axis in response to stress is also
associated with cognitive dysfunction in aged animals (Issa
et al., 1990; Bizon et al., 2001). In addition, HPA activity
was blunt in elderly compared to young adult participants
(Hatzinger et al., 2011). Therefore, new therapeutic approaches
acting on the HPA axis and its receptor signaling should take
into account.
Activation of the septo-hippocampal cholinergic system is
considered as an important aspect in the adaptive response
to stress and is influenced by neuronal and hormonal
stimuli. This septo-hippocampal activation seems to initialize
following activation of the pituitary-adrenocortical axis (Gilad
et al., 1985; Gilad, 1987) and may then affect glucocorticoid
secretion via the HPA axis (Herman et al., 1996). The HPA
axis plays an important role in the adaptation to stress
by modulating hippocampal activity. Thus, the hippocampus,
along with cholinergic innervation from the BF, is involved
in regulating the HPA axis stress response. Activation of
the HPA axis mediates responses that enable an organism
to maintain its homeostasis. Hence, neurodegeneration of
cholinergic neurons, a pathological characteristic in AD and
aging, makes the elderly vulnerable to stress, resulting in
cognitive impairment.
The extent to which the cholinergic system is involved in
stress, cognition, and neurological disorders has been reported
in several significant research reports. Therefore, we attempt
to develop a supporting background for our recent studies in
rats (aged or with cholinergic lesions) on HPA axis dysfunction
in response to stress and altered glucocorticoid receptor (GR)
signaling in the hippocampus. We also describe the interactive
link between the glucocorticoid and cholinergic systems in aging
and stress.
Overview of the Basal Forebrain
Cholinergic System
An anatomical simplified overview of BF cholinergic neurons
is summarized in Figure 1, including cells located in the
medial septum (MS), the vertical limb of the diagonal band
of Broca (VDB), and the nucleus basalis of Meynert–extending
to the substantia innominata in the rodent brain. These
structures send cholinergic projections to a broad range
of neocortical sites as well as structures in the limbic
system, including the hippocampus (Mesulam et al., 1983;
Gallagher and Colombo, 1995). Thus, the septo-hippocampal
pathway, which arises from the medial septal nucleus and
nucleus of the diagonal band, is the main structure of the
central cholinergic system and the main source of cholinergic
innervation to the hippocampal formation. A topographical
model of the septo-hippocampal pathway has been constructed
based on various lesion, tracing, and immunocytochemical
methods in the septal and hippocampal regions (Lewis
et al., 1967; Dutar et al., 1995). The MS is connected
to the hippocampus, via the fimbria and dorsal fornix,
and to the medial cortex (Lewis and Shute, 1967; Teles-
Grilo Ruivo and Mellor, 2013). The cornu ammonis (CA)
1 pyramidal and dentate granule (DG) cell layers in the dorsal
hippocampus receive afferent inputs from the VDB, and these
cell layers in the ventral hippocampus receive inputs from
the both MS and VDB (McKinney et al., 1983; Nyakas et al.,
1987).
Cholinergic Hypothesis in Disease Etiology
The cholinergic hypothesis has been implicated in the etiology
of AD, various types of dementia, and aging, and is rooted
in degeneration of BF cholinergic neurons causing cognitive
deficit (Bartus et al., 1982; Bartus, 2000; Sarter et al., 2003). This
theory, however, remains controversial. Although enhancement
of cholinergic function by cholinergic agents (e.g., AChE
inhibitors) in AD and age-related cognitive deficit supported
the hypothesis, other research subsequently pinpointed the
involvement of other factors, such as dopamine projections
to the frontal cortex, amyloid deposition, and increased
glucocorticoid levels (Dumas and Newhouse, 2011). More
specifically, hypersecretion of glucocorticoid, or A-beta-altered
HPA axis function, have been implicated in hippocampal
impairment in AD (Hibberd et al., 2000; Brureau et al., 2013)
Additionally, elevated glucocorticoid levels and impaired GR
signaling are associated with HPA dysfunction, resulting in
cognitive decline in elderly subjects (Issa et al., 1990; Lupien
et al., 1994; Bizon et al., 2001; Mizoguchi et al., 2009). Therefore,
a possible pathophysiological link between glucocorticoids and
the age-dependent decline in BF cholinergic function, especially
in the CA1, CA3, and DG regions of hippocampus, has also
been established (Hörtnagl et al., 1993). Craig et al. postulated
a new cholinergic hypothesis version for AD, where loss of
MS cholinergic input to the hippocampus induces hippocampal
vulnerability, resulting in greater cognitive impairment in
response to subsequent insults, such as stress or injury (Craig
et al., 2011).
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FIGURE 1 | Illustrated overview of the basal forebrain cholinergic
pathway. Cholinergic projections include the medial septum (MS), vertical
limbs of the diagonal band of Broca (vDB), nucleus basalis of Meynert
(NBM), and substantia innominate (SI) projecting to the hippocampus,
thalamus, olfactory bulb, and cortical region. Cholinergic
pontomesencephalon neurons include laterodorsal tegmental (LDT) and
pedunculopontine tegmental nuclei (PPT) projecting to hindbrain, thalamus,
hypothalamus, and basal forebrain.
Implication of Lesion Studies in Evaluating
Cholinergic Innervation
Application of the cholinergic hypothesis to animal model
offers the ability to evaluate functional network and molecular
pathway to understand neurocognitive diseases. Selection of
animal (even among rodents) is important, as they differ in
cholinergic tone, receptor activation, and relevance to human
basal cholinergic activity (Van der Zee and Keijser, 2011). The
adoption of the rodent as an animal model may compliment
studies in primates due to effectiveness and cost-efficiency.
Moreover, features such as short lifespans are an important factor
to be considered in the study of late-onset or aging diseases
(Gallagher et al., 2011). One major pathological hallmark of
neurodegenerative disease that cause cognitive decline, is the
dramatic loss of BF cholinergic projection neurons with reduced
cholinergic innervation to the hippocampus and neocortex
(Davies and Maloney, 1976; Whitehouse et al., 1981; Arendt
et al., 1983; Mesulam, 2004). Additionally, the relative loss of
cholinergic neurons and the decrease of the ACh synthesizing
enzyme, choline acetyltransferase in the brain of AD patients is
associated with cognitive impairment (Bartus, 2000). In animal
studies, neurotoxin-induced BF lesions cause similar cognitive
impairments (Olton, 1990). However, lesioning cholinergic BF
neurons is challenging because they are intertwined with non-
cholinergic neurons and there is a risk of damaging adjacent
structures.
Although BF lesions using conventional lesion methods
(e.g., electrolytic) produce varying manifestations of cognitive
impairment, the development of methods that selectively
interrupt the BF region has been attempted (Easton et al.,
2012; Baxter and Bucci, 2013). An initial approach innovatively
used 192IgG-saporin, a neurotoxin with a specific affinity
for cholinergic neuron cell surface receptors (Wiley et al.,
1991; Baxter and Bucci, 2013). A myriad of studies picked
the hippocampal and septo-hippocampal regions of the BF as
lesion sites to evaluate the cholinergic interventions observed in
aging and cognition. Studies with selective BF neurotoxic lesion
concluded this region was associated with cognitive function
characterized by attention (Muir et al., 1993; Baxter et al., 1997,
1999; Bucci et al., 1998; Chiba et al., 1999; Chudasama et al.,
2004), and learning andmemory (Hepler et al., 1985; Hagan et al.,
1988; Berger-Sweeney et al., 1994; Baxter et al., 1995; Janisiewicz
et al., 2004). Furthermore, a significant correlation between
cognitive impairment and decline in cholinergic markers for
the septo-hippocampal projection in aged rats (Gallagher et al.,
1990; Smith and Booze, 1995) supports the involvement of BF
cholinergic neurons in cognition. More recently, animals with
a saporin-induced partial loss of septo-hippocampal cholinergic
neurons exhibited cognitive deficit (Brayda-Bruno et al., 2013).
Other lesion studies extended the importance of the BF
cholinergic system in the process of functional recovery from
brain injury in young rats (Conner et al., 2005), which is
intriguing in that animals with BF lesions may show deficits
in cognitive function. Selective lesion of cholinergic inputs to
the hippocampus has also been used to evaluate the effects of
cholinergic receptors in regulating hippocampal ACh release
(Thorne and Potter, 1995).
Though lesion studies have generated substantial controversy,
the advent of this approach has generated new empirical
tests and compelling information on the potential function of
cholinergic and non-cholinergic neurons emanating from the
BF. Additionally, this has unveiled the possible role played by
loss of these neurons in stress, aging, and other neurocognitive
diseases. More essentially, animal models are indispensable for
recreating specific human pathogenic events, and invaluable for
drug screening and therapeutic intervention assessment.
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HPA Axis and Glucocorticoids in Stress
Regulation and Aging
The HPA axis is an integral component in promoting resilience
to stress. Most salient age-related changes in the stress response
are thought to occur in the HPA axis. The HPA system is
classically controlled by a range of afferent signals responsible
for the coordinated release of various signaling markers.
The hypothalamus is at the top of the hierarchy in the
control of the central HPA axis. When the brain perceives
a stressor, activation of the paraventricular nucleus of the
hypothalamus triggers the release of corticotropin-releasing
hormone. Corticotropin-releasing hormone stimulates pituitary
adrenocorticotropic hormone (ACTH) release and activates the
adrenal gland, which secretes glucocorticoids (cortisol in humans
and corticosterone in rodents). Glucocorticoids released from the
adrenal gland interact with the HPA axis by binding to specific
GRs in the brain, forming a closed-loop feedback system and
subsequently coping with stress (Sapolsky et al., 1986; Mizuno
and Kimura, 1997; Srinivasan et al., 2013). Thus, glucocorticoids
are the end product of the HPA axis and regulate a wide
array of actions influencing neuronal function and metabolism
(Figure 2).
Two types of steroid hormone receptors have been identified
in tandem in the brain: the mineralocorticoid receptor (MR)
and the GR. Expression of MR is considerably more restricted
in the brain compared to the ubiquitous expression of GR, and
both mediate classical genomic and non-genomic glucocorticoid
actions by acting as nuclear transcriptional activators and
repressors (Reul and de Kloet, 1985; Joëls, 2008; van der
Laan and Meijer, 2008; Groeneweg et al., 2011). Moreover,
the secretion of glucocorticoids and their binding to receptors
leads to auto-regulatory decreases in receptor availability and
vice versa (Sapolsky et al., 1984; Reul et al., 1987a,b). Actions
of GR described above extends the role of GR beyond
mediating glucocorticoid feedback following stress, whereas
MR participates in basal HPA tone (Reul et al., 1987a; De
Kloet et al., 1998) and the genomic action in adaptation
and homeostasis after stress exposure (de Kloet, 2008). After
GR binding, these activated receptors are translocated to the
nucleus where they bind to the glucocorticoid responsive
elements (GRE) and affect the transcriptional activity of
target genes (Funder, 1997). Stress causes a down-regulation
of GR through the increase of circulating glucocorticoids,
eventually decreasing sensitivity to nuclear transcriptional
activities. Glucocorticoid-GR can also activate transcription by
binding directly as a homodimer to the GRE DNA sequence
present in the promotors of target genes (e.g., serum- and
glucocorticoid-induced protein kinase, mitogen-activated protein
kinase phosphatase-1, etc) that has been reported to regulate
cognitive function (Lee et al., 2007; Vyas and Maatouk, 2013;
Cestari et al., 2014).
HPA activity tends to increase with age due to inefficiencies of
glucocorticoid negative-feedback inhibition, resulting in elevated
plasma levels of ACTH and glucocorticoids (Mizoguchi et al.,
2009; Aguilera, 2011). A decrease in glucocorticoid negative-
feedback inhibition is associated with the loss of GR and altered
FIGURE 2 | Schematic diagram showing the role of the hippocampus
in modulating the HPA (hypothalamic pituitary adrenocortical) axis.
Stress triggers the release of glucocorticoids, which exerts feedback to the
hippocampus, hypothalamus, and pituitary. Acetylcholine (ACh) is also
involved in mediating neuroendocrine, emotional, and physiological responses
in tandem with the HPA axis. AChR, acetylcholine receptors; GR,
glucocorticoid receptor; MR, mineralocorticoid receptor; CRH,
corticotropin-releasing hormone; ACTH, adrenocorticotropic hormone.
GR signaling in the forebrain (Issa et al., 1990; Bizon et al.,
2001; Lund et al., 2004; Lee et al., 2012). Increased levels of
glucocorticoids appear to threaten hippocampal neurons and
direct the loss of dendrite complexity in the hippocampus
(Hibberd et al., 2000). Inappropriate HPA axis regulation in
aging is reviewed by Aguilera (2011) who stresses its adverse
effect in stress-related brain disorders.
A link between HPA deregulation and disruption of GR
has been observed in AD and other neurodegenerative diseases
(Brureau et al., 2013; Vyas and Maatouk, 2013). Interestingly,
though extra-hypothalamic GR sites receive attention for
this glucocorticoid-mediated HPA inhibitory feedback; the
hippocampus receives the utmost attention with regards to these
effects (McEwen et al., 1968, 1969; Sapolsky et al., 1984, 1986;
Herman et al., 1989). The influence of glucocorticoids on the
HPA axis markedly depends on the available GR in individual
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tissues (Simons, 2008). Abundant expression of GR in the
forebrain (McEwen et al., 1969;McEwen andWallach, 1973), and
increased activity of the HPA axis in the absence of forebrain
inhibition on HPA axis by damage of the forebrain (Jacobson
and Sapolsky, 1991; van Haarst et al., 1996), contributes to
the sequelae associated with GR malfunction. Taken together,
forebrain GR expression is critical for HPA axis regulation in
response to stress (Furay et al., 2008) and further adduces the role
of GR in stress.
Cholinergic Neuron in Stress Regulation
via HPA Axis and Cognitive Function
A further increase in ACh release was observed in the hippo-
campus after acute stress (Finkelstein et al., 1985; Gilad et al.,
1985; Imperato et al., 1989). Corticosterone administration,
mimicking the increase in the plasma corticosterone
concentration produced by stress, induced hippocampal
ACh (Imperato et al., 1989). These studies support the
involvement of glucocorticoids in the cholinergic innervation
of the hippocampus, and the activation of the HPA axis in
the process. Stress-induced responses activated the septo-
hippocampal cholinergic pathway within minutes (Gilad,
1987), which then induced ACh-mediated neuroendocrine,
emotional, and physiological responses by stimulating the
HPA axis (Newman et al., 2001). This HPA axis activation
led to the release of corticosterone, a stress neurohormone
(Nyakas et al., 1987; Calogero et al., 1988, 1990). Increased
release of hippocampal ACh and glucocorticoids in response
to stress was observed in young rats, but not in aged rats
(Mizuno and Kimura, 1997). However, contradictory results
have been reported. Proteomic analyses of the hippocampus of
rats exposed to stress showed a decrease in a precursor protein
of hippocampal cholinergic neurostimulating peptide (HCNP)
leading to a loss of ACh production (Kim and Kim, 2007).
HCNP stimulate the enzyme activity of choline acetyltransferase
in neurons. It is also reported that expression levels of HCNP
precursor protein mRNA were decreased in the hippocampus
of AD patients (Maki et al., 2002). These reports indicate a
possible intricate interplay between the level of glucocorticoids,
ACh, and hippocampal cholinergic protein expression effecting
septo-hippocampal cholinergic pathways.
Interestingly, a parallel increase in both plasma corticosterone
and hippocampal ACh level has been validated as a consequence
of elevated platform exposure, a relatively mild stress (Degroot
et al., 2004). The interaction of glucocorticoid with ACh in
the brain is well reviewed (Mora et al., 2012). Moreover,
regulation of the HPA axis by glucocorticoid feedback and
cholinergic brain function modulating stress responses depends
on the intensity and predictability of stressful stimuli (Pitman
et al., 1988; Martí and Armario, 1997; Morris and Rao,
2014).
Although ACh mediates its effects via both types of ACh
receptors, mAChR are more involved in cognitive impairment
and are densely present in the hippocampus (Dutar et al.,
1995; Colgin et al., 2003; Drever et al., 2011). An excessive
loss of mAChR in the hippocampus of Alzheimer’s patients,
and severely impaired muscarinic signaling associated with
age-related cognitive decline (Bartus et al., 1982; Zhang
et al., 2007), reveal the connection between the muscarinic-
dependent cholinergic system and cognitive impairment.
Scopolamine-induced mAChR blockade resulted in cognitive
deficit in healthy adult humans (Voss et al., 2010). Additionally,
mAChR antagonists significantly elevated plasma corticosterone
in stressed rats, suggesting an inhibitory effect of mAChR
stimulation on pituitary-adrenal function (Kile and Turner,
1985). This result is indicative of a correlation between
corticosterone levels, mAChR availability, and cognitive
function.
Basal Forebrain Cholinergic Neurons,
Hippocampal Glucocorticoids, and
Glucocorticoid Receptor in Stress Regulation
and Cognitive Aging
The hippocampus is a brain structure crucially involved in
memory, the neuroendocrine regulation of stress hormones, and
termination of the stress response via HPA axis glucocorticoid-
mediated inhibition (Mizuno and Kimura, 1997; Kim and
Diamond, 2002). Studies showing hippocampal damage due
to prolonged exposure to glucocorticoids or chronic stress in
primates (Uno et al., 1989; Sapolsky et al., 1990) have been
triggered an assessment of the cumulative impact of such
exposures on the hippocampus using other animals. A number
of studies reported that chronic stress or glucocorticoids
contributed hippocampal cell death in adult rats (Sapolsky et al.,
1985; Dachir et al., 1997). The hippocampus contains a high
density of GR and is a target of glucocorticoid actions. Cognitive
deficits are associated with a loss of hippocampal neurons,
in particular pyramidal cells, due to increased glucocorticoid
exposure (McEwen et al., 1968; McEwen, 1999; Hibberd et al.,
2000). However, others failed to find hippocampal neuronal
loss in rats (Bodnoff et al., 1995; Sousa et al., 1998; Coburn-
Litvak et al., 2004), tree shrews (Vollmann-Honsdorf et al.,
1997; Fuchs et al., 2001), primates (Leverenz et al., 1999), and
humans (Müller et al., 2001). The inconsistencies in literatures
on glucocorticoid-related cell death may arise from species-
specific differences in expression levels of GR and MR (Conrad,
2008).
In any case, impairments of hippocampal dependent
memory and synaptic plasticity, and structural alterations
have been observed in the animals with chronic stress or
corticosterone treatment (Bodnoff et al., 1995; Fuchs et al.,
2001; Finsterwald and Alberini, 2014). Down-regulation of
GR in the hippocampus follows the chronic corticosterone
treatment. (Tornello et al., 1982). And GR signaling was altered
in stress-related psychopathologies (Finsterwald and Alberini,
2014). Thus this indicates a connection between GR availability
and cognitive function. As GR are responsible for negative
feedback control of the adaptive stress response (De Kloet
et al., 1998), a reduction in hippocampal GR is associated
with post-stress glucocorticoid hypersecretion (Sapolsky,
1996). Additionally, glucocorticoid treatments exacerbated
the cholinergic neurotoxin ethycholine aziridinium (AF64A)-
induced cholinergic lesions in the hippocampus, suggesting
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a pathophysiological link between glucocorticoids and age-
dependent declines in cholinergic function or cholinergic
degeneration in AD (Hörtnagl et al., 1993). Moreover, the
essential coordinating role of GR in regulating glucocorticoid
secretion through the HPA axis in response to stress in aging is
well documented (Issa et al., 1990; Herman et al., 1996; Bizon
et al., 2001; Murphy et al., 2002; Furay et al., 2008; Mizoguchi
et al., 2009).
Glucocorticoid receptor, when functioning as a ligand-
dependent transcription factor, controls transcription by directly
binding to positive and negative GRE, regulating transcriptional
increases (anti-inflammatory) or decreases (HPA axis negative
feedback) or inhibiting transcriptional activity of other factors
(on pro-inflammatory molecules) (Silverman and Sternberg,
2012). The GR-DNA binding phenomenon is gradually receiving
recognition, and research on the anti-inflammatory effects of
GR-DNA binding has been reported in in vivo and in vitro
studies (Reichardt et al., 1998, 2001; Schäcke et al., 2002; Clark,
2007). Target disruption of GR genes and impaired GR-DNA
binding has been correlated with cognitive deficits in mice
(Oitzl et al., 1997, 2001), while intra-hippocampal GR blockade
with a GR antagonist produced memory impairments (Nikzad
et al., 2011). Diminished GR signaling and GR mRNA in the
aged hippocampus is related to memory impairment and HPA
axis dysregulation (Bizon et al., 2001; Murphy et al., 2002; Lee
et al., 2012). Furthermore, a decrease in the nuclear uptake
of corticosterone, decreased nuclear translocation, and DNA
binding deficits were observed in the hippocampus of the aged
rat (Sapolsky et al., 1983; Murphy et al., 2002; Lee et al.,
2012). This highlights the need to understand glucocorticoids-
genomic interactions, as this may illuminate the role of GR in
cognitive processes. Reduced expression of GR mRNA in the
hippocampus and medial prefrontal cortex was also observed
with memory-impaired aged rats relative to young controls
and memory-unimpaired aged rats, with no change in the
basal levels of circulating glucocorticoids (Bizon et al., 2001).
Another source of GR signaling interference in hippocampal
cognition may be mediated by the regulation of other intruding
nuclear transcriptional factors, such as activator protein and
nuclear factor κB (NF-κB; Yang-Yen et al., 1990; McKay and
Cidlowski, 1998; Lund et al., 2004). Recently, reduced expression
of FKBP5, a key GR modulator, and smaller hippocampal
volumes were observed in posttraumatic stress disorder, which
was reversed after cognitive behavioral therapy (Levy-Gigi et al.,
2013). Supporting the above facts, decreased nuclear GR mRNA
and protein was observed in aged rats with cognitive impairment,
suggesting defective GR transportmight affect the transcriptional
properties of hippocampal neurons with HPA axis dysfunction
and could have age-related impact on cognitive decline and
the loss of stress regulation (Bizon et al., 2001; Lee et al.,
2012).
Although high levels of glucocorticoids are not associated
with the loss of hippocampal neurons (Leverenz et al., 1999),
some studies suggest interplay between the accumulative factor
of stress and aging in the process of cell loss (Hibberd et al., 2000).
On the other hand, Notarianni recently proposed a role for GR
signaling in the initiation and development of AD, implicating
over-activation of GR with hypercortisolemia in promoting
amyloid beta (Aβ) production that leads to Aβ deposition and
associated neuroinflammation (Notarianni, 2013).
Chronic neuroinflammation in the BF is also linked to loss of
cholinergic neurons and is responsible for cognitive impairment
associated with aging and AD (Willard et al., 1999). Significant
loss of cholinergic neurons in the MS/diagonal band was also
observed in aged animals with memory impairment (Baskerville
et al., 2006). A direct correlation between glucocorticoid
regulation of GR via the HPA axis and impaired GR function as
a mechanism for inflammation is well reviewed (Silverman and
Sternberg, 2012), emphasizing its importance in the prevention
and management of chronic stress. Further, upregulation of pro-
inflammatory cytokines occurs in the cortex and hippocampus of
rats with post-surgery stress, resulting in post-operative cognitive
dysfunction. This surgery-induced inflammation can be reduced
by acetylcholinesterase inhibitors (Kalb et al., 2013), pointing
to the involvement of the cholinergic system in cognitive
impairment associated with neuroinflammation.
Interaction of ACh Receptor and GR in the
Hippocampus
Cognitive impairment was observed in healthy human subjects
treated with scopolamine, a selective mAChR antagonist (Voss
et al., 2010). Rats treated with scopolamine showed spatial
working memory impairment in an 8-arm radial maze task and
alterations in ventral hippocampi ACh release (Mishima et al.,
2000). In addition, impairment of recognition memory in BF
cholinergic lesioned animals was aggravated by scopolamine,
emphasizing the importance of mAChR in cognitive function
(Steckler et al., 1995). Deficit in the transduction of cholinergic
mAChR signals has been detected in the hippocampus of aged
rats (Smith and Booze, 1995), the cortex of aged monkeys
(Vannucchi and Goldman-Rakic, 1991), and in AD patients
(Flynn et al., 1991). Additionally, impaired mAChR binding was
found in the striatum and hippocampus of aged rats (Anson et al.,
1992; Yamagami et al., 1992; Nieves-Martinez et al., 2012).
Loss of mAChR exacerbates cognitive decline and AD
pathology, such as increased plaques/tangles and cerebrovascular
deposition of Aβ in AD mice (Medeiros et al., 2011). Treatment
with selectivemuscarinic agonists resulted in reduced production
of Aβ in AD patients (Hock et al., 2003). A speculative pathway,
due to loss of mAChR function in rats, induced by selective
hippocampal cholinergic lesions with AF64A is predicted to
influence effects in stimulating nicotinic receptors that may
modulate the release of ACh (Thorne and Potter, 1995). In
context, it is predicted that loss of mAChR function might
exert stimulatory effects on nicotinic receptors, which are well
described in cognitive functions (Levin, 2013). This highlights
the importance of mAChR in BF cognitive function. Decreased
expression of mAChR in the hippocampal CA1 region of aged
epileptic animals (Cavarsan et al., 2011), and severely impaired
muscarinic signaling in the hippocampus of cognitively impaired
rats (Zhang et al., 2007), illustrates the involvement of the
cholinergic system with cognition. More recently, decreases in
ACh and mAChR were observed in cognitively impaired mice
(Park et al., 2013). Additionally, impaired hippocampal ACh
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release and cognitive deficits in mAChR knockout mice (Tzavara
et al., 2003) coupled with mAChR antagonist impairment of
memory in aged rats (Quirion et al., 1995; Klinkenberg and
Blokland, 2010) implies a role for mAChR in the cholinergic
hypothesis of cognition.
Activation of septo-hippocampal cholinergic neurons is
manifested by increased release of ACh and choline uptake.
This choline uptake is reduced below control levels in the
presence of chronic stress, followed by an up-regulation of
muscarinic binding sites (Finkelstein et al., 1985). Suppression
of glucocorticoid secretion enhances hippocampal cholinergic
transmission in rats (Mizoguchi et al., 2008). Furthermore,
enhanced memory consolidation by striatal corticosterone
injection was blocked by administration of scopolamine
(Sánchez-Resendis et al., 2012), confirming the interactive
relationship between glucocorticoids and cholinergic receptor.
Glucocorticoid modulation of mAChR in lung (Scherrer et al.,
1997), smooth muscle (Emala et al., 1997), chronic obstructive
pulmonary disease (Johnson, 2005), and several brain nuclei
in rats (Torres et al., 1991) suggests a similar pattern in
hippocampal cholinergic neurons.
Rats with selective removal of hippocampal cholinergic input
showed HPA axis dysfunction and decreased hippocampal
GR levels (Han et al., 2002; Helm et al., 2002, 2004; Lim
et al., 2012). Subsequent studies also revealed altered GR-
protein kinase A (PKA)-NF-κB signaling in the hippocampus
with loss of cholinergic input (Lim et al., 2011, 2012).
The study regarding interactive effects of stress with loss of
BFCN on cognitive function reported chronic stress induced
impairment of working memory in rats with loss of hippocampal
cholinergic input (Craig et al., 2008). Recently, we examined
whether chronic stress aggravated cognitive deficit induced
by selective BF cholinergic lesions leading to alterations in
GR-PKA-NF-κB signaling. Lesioned rats receiving chronic
stress showed a severe impairment in spatial memory and
increased NF-κB signaling activation, which was substantiated by
increased hippocampal pro-inflammatory gene expression, such
as inducible nitric oxide synthase and cyclooxygenase-2 (Lee
et al., 2013). These data indicate that the interaction between GR
and ACh receptors is associated with stress-induced cognitive
dysfunction.
Conclusion
The present review summarizes the current research
and shows the importance of glucocorticoids and their
receptor in modulating cognition in stress, aging, and AD
via the cholinergic system. This may pave a new way in
understanding the progression of the aforementioned diseases.
Therefore, this review facilitates the understanding of the
following: (1) involvement of both GR and ACh receptors in
modulating cognition, thus providing a palliative approach for
pharmaceutical interventions as these receptors are discussed
in many research papers as a route to therapeutic intervention;
(2) an interactive platform to mark the holistic consequences
of cognitive impairment converging from varied neurological
deficits; and finally; (3) an interactive role of glucocorticoids in
the development of cognitive dysfunction and vulnerability of the
hippocampus to such exposure. The main objective of this review
was not only to highlight the possible underlying association
between the various pathways and neural circuits involved
in cognitive impairment, but also to enable the mitigation of
such stress-induced cognitive morbidity by developing more
effective pharmacotherapeutic strategies to ameliorate such
diseases.
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